Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

duloksetin - gastrorezistentna kapsula, trda - duloksetin 30 mg / 1 kapsula - duloksetin

Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

duloksetin - gastrorezistentna kapsula, trda - duloksetin 30 mg / 1 tableta - duloksetin

Słowenia - słoweński - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

duloksetin - gastrorezistentna kapsula, trda - duloksetin 60 mg / 1 tableta - duloksetin

Unia Europejska - słoweński - EMA (European Medicines Agency)

pfizer europe ma eeig  - abrocitinib - dermatitis, atopic - drugi dermatološki preparati - cibinqo is indicated for the treatment of moderate-to-severe atopic dermatitis in adults who are candidates for systemic therapy.

Unia Europejska - słoweński - EMA (European Medicines Agency)

amgen europe bv - sotorasib - karcinom, pljučni pljuč - antineoplastična sredstva - lumykras as monotherapy is indicated for the treatment of adults with advanced non-small cell lung cancer (nsclc) with kras g12c mutation and who have progressed after at least one prior line of systemic therapy.

Unia Europejska - słoweński - EMA (European Medicines Agency)

idorsia pharmaceuticals deutschland gmbh - daridorexant hydrochloride - motnje v zvezi s spanjem in vzdrževanjem - psiholeptiki - quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.

Unia Europejska - słoweński - EMA (European Medicines Agency)

abbvie deutschland gmbh & co. kg - atogepant - bolezni migrene - aquipta is indicated for prophylaxis of migraine in adults who have at least 4 migraine days per month.